Kiniksa Pharmaceuticals, Ltd. KNSA

$ 21.31 1.05%

Quarterly report 2024-Q3
added 10-29-2024

Kiniksa Pharmaceuticals, Ltd. Total Current Liabilities 2011-2024 | KNSA

Annual Total Current Liabilities Kiniksa Pharmaceuticals, Ltd.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
63.7 M	47.1 M	44.8 M	31.8 M	27.8 M	42.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
63.7 M	27.8 M	43 M